Abstract
Technological advances coupled with novel collaborative strategies for compound sourcing and management are poised to transform the utility of high-throughput screening.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Fluorescence-based assay as a new screening tool for toxic chemicals
Scientific Reports Open Access 22 September 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Macarron, R. et al. Impact of high throughput screening in biomedical research. Nat. Rev. Drug. Discov. 10, 188–195 (2011).
Cook, D. et al. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework. Nat. Rev. Drug Discov. 13, 419–431 (2014).
Bakken, G. A. et al. Shaping a screening file for maximal lead discovery efficiency and effectiveness: elimination of molecular redundancy. J. Chem. Inf. Model. 52, 2937–2949 (2012).
Simpson, P. B. & Reichman, M. Opening the lead generation toolbox. Nat. Rev. Drug Discov. 13, 3–4 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.R, K.B. and G.P. are employees of AstraZeneca.
Rights and permissions
About this article
Cite this article
Rees, S., Gribbon, P., Birmingham, K. et al. Towards a hit for every target. Nat Rev Drug Discov 15, 1–2 (2016). https://doi.org/10.1038/nrd.2015.19
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2015.19
This article is cited by
-
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Nature Reviews Drug Discovery (2018)
-
Directing evolution: the next revolution in drug discovery?
Nature Reviews Drug Discovery (2017)
-
Fluorescence-based assay as a new screening tool for toxic chemicals
Scientific Reports (2016)